Notice2021-24994
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 16, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Requirement for Negative Pre- Departure COVID-19 Test Result or Documentation of Recovery from COVID- 19 For All Airline or Other Aircraft Passengers Arriving into the United States from any Foreign Country and Requirement for Proof of COVID-19 Vaccination for Noncitizen, Nonimmigrant Air Passengers Arriving Into The United States From A Foreign Country. This proposed information collection is designed to ensure that CDC complies with Orders published October 25 and October 30, 2021, and to confirm that passengers who are coming into the United States via air travel have tested negative for or recently recovered from COVID-19, and that noncitizen, nonimmigrant passengers are fully vaccinated against COVID- 19.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 218 (Tuesday, November 16, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 218 (Tuesday, November 16, 2021)]
[Notices]
[Pages 63397-63399]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-24994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1318; Docket No. CDC-2021-0124]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Requirement for Negative Pre-
Departure COVID-19 Test Result or Documentation of Recovery from COVID-
19 For All Airline or Other Aircraft Passengers Arriving into the
United States from any Foreign Country and Requirement for Proof of
COVID-19 Vaccination for Noncitizen, Nonimmigrant Air Passengers
Arriving Into The United States From A Foreign Country. This proposed
information collection is designed to ensure that CDC complies with
Orders published October 25 and October 30, 2021, and to confirm that
passengers who are coming into the United States via air travel have
tested negative for or recently recovered from COVID-19, and that
noncitizen, nonimmigrant passengers are fully vaccinated against COVID-
19.
DATES: CDC must receive written comments on or before January 18, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0124 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://Regulations.gov">Regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#7f10121d3f1c1b1c51181009"><span class="__cf_email__" data-cfemail="91fefcf3d1f2f5f2bff6fee7">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology,
[[Page 63398]]
e.g., permitting electronic submissions of responses; and
5. Assess information collection costs.
Proposed Project
Requirement for Negative Pre-Departure COVID-19 Test Result or
Documentation of Recovery from COVID-19 For All Airline or Other
Aircraft Passengers Arriving into the United States from any Foreign
Country and Requirement for Proof of COVID-19 Vaccination for
Noncitizen, Nonimmigrant AirPassengers Arriving Into The United States
From A Foreign Country (OMB Control No. 0920-1318, Exp. 5/31/2022)--
Revision--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Since January 2020, the respiratory disease known as ``COVID-19,''
caused by a novel coronavirus (SARS-CoV-2), has spread globally,
including cases reported in all 50 states within the United States,
plus the District of Columbia and all U.S. territories. As of October
22,2021, there have been over 242,000,000 million cases of COVID-19
globally, resulting in over 4,900,000 deaths. More than 45,000,000
cases have been identified in the United States, with new cases
reported daily, and over 733,000 deaths have been attributed to the
disease. Many countries have begun widespread vaccine administration;
however, 98 countries continue to experience high or substantial
incidence rates (>50 cases per 100,000 people in the last seven days)
and 65 countries, including the United States, are experiencing a high
incidence of reported new cases at this time.\19\
SARS-CoV-2 spreads mainly from person-to-person through respiratory
fluids released during exhalation, such as when an infected person
coughs, sneezes, or talks. Exposure to these respiratory fluids occurs
in three principal ways: (1) Inhalation of very fine respiratory
droplets and aerosol particles, (2) deposition of respiratory droplets
and particles on exposed mucous membranes in the mouth, nose, or eye by
direct splashes and sprays, and (3) touching mucous membranes with
hands that have been soiled either directly by virus-containing
respiratory fluids or indirectly by touching surfaces with virus on
them. Spread is more likely when people are in close contact with one
another (within about 6 feet), especially in crowded or poorly
ventilated indoor settings. Persons who are not fully vaccinated,
including those with asymptomatic or pre-symptomatic infections, are
significant contributors to community SARS-CoV-2 transmission and
occurrence of COVID-19. New variants of SARS-CoV-2 have emerged
globally, several of which have been identified as variants of concern,
including the Delta variant. Some variants are more transmissible and
some may cause more severe disease, which can lead to more
hospitalizations, and deaths among infected individuals.
On October 25, 2021 CDC amended its January 25, 2021 Order, titled,
``Requirement for Proof of Negative COVID-19 Test or Recovery from
COVID-19 for All Air Passengers Arriving in the United States.'' This
amendment updates COVID-19 testing requirements for air passengers two
years or older boarding a flight to the United States, depending on
COVID-19 vaccination status. Those who are fully vaccinated will need
to provide a negative pre-departure COVID-19 test conducted with a
specimen no more than 3 days before travel to the US, as well as proof
of being fully vaccinated. While those who are not fully vaccinated
will need to provide a negative pre-departure COVID-19 test conducted
with a specimen no more than one day of before travel to the U.S.
The Order requiring a negative COVID-19 test or documentation of
recovery has a list of categorical exemptions that would not be subject
to this information collection. These include, crew members of airlines
or other aircraft operators who follow industry standard protocols for
the prevention of COVID-19; airlines or other aircraft operators
transporting passengers with COVID-19 pursuant to CDC authorization and
in accordance with CDC guidance; U.S. federal law enforcement personnel
on official orders; U.S. military personnel, including civilian
employees, dependents, contractors, and other U.S. government employees
when traveling on U.S. military assets; and any person who may apply
and receive a time limited exemption for urgent humanitarian reasons.
Also on October 25, 2021, President Biden issued a Proclamation
``Advancing Safe Resumption of Global Travel During the COVID-19
Pandemic''. This Proclamation allowed CDC to issue an Order
Implementing Proclamation on Advancing Safe Resumption of Global Travel
During the COVID-19 Pandemic on October 25, 2021, followed by an
amendment on October 30, 2021 which provided minimal updates and
superseded the October 25, 2021 Order.
This Proclamation and Order will only apply to noncitizen,
nonimmigrants. It will not apply to any person who is a U.S. citizen,
U.S. national, lawful permanent resident, or immigrant. The
Proclamation also does not apply to crew members of airlines or other
aircraft operators if they follow industry standard protocols for the
prevention of COVID-19. Some noncitizen, nonimmigrants who are not
fully vaccinated, as defined by the Order, may fall into a category
that allows them to be excepted to the requirement if they can present
to an airline or aircraft operator that they meet the criteria for that
category, such as letters confirming registration in a vaccine clinical
trial, or U.S. military identification.
For information collection activities associated with these Orders,
CDC requests OMB approval for an estimated 352,538,030 annual burden
hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Air Passenger................. Section 1 of 123,000,000 1 2 246,000,000
Combined
Passenger
Disclosure and
Attestation to
the United
States of
America.
Noncitizen Nonimmigrant Air Section 2 of 90,000,000 1 1 90,000,000
Passenger. Combined
Passenger
Disclosure and
Attestation to
the United
States of
America.
[[Page 63399]]
Airline Desk Agent............ Combined 123,000,000 1 8/60 16,400,000
Passenger
Disclosure and
Attestation to
the United
States of
America.
Air Passenger................. Request 600 1 2 1,000
Humanitarian
Exemption to
COVID-19 Test
or
Documentation
of Recovery.
Noncitizen Nonimmigrant Air Request 600 1 2 1,000
Passenger. Humanitarian or
Emergency
Exception to
Proof of
Vaccination
Requirement.
Air Passenger (undergoing Questions Asked 1,230,000 1 5/60 102,500
compliance check). to Air
Passengers
Going Through
Compliance
Checks.
Air Passenger (undergoing Air Travel 7,380 1 10/60 1,230
compliance check with non- Illness or
compliant documentation). Death
Investigation
or Traveler
Follow-up Form.
Noncitizen Nonimmigrant Air Air Travel 190,000 1 10/60 31,667
Passenger (undergoing Illness or
compliance check and using Death
humanitarian or emergency Investigation
exception). or Traveler
Follow-up Form.
Air Traveler (for illness or Air Travel 1,700 1 15/60 425
death investigation). Illness or
Death
Investigation
or Traveler
Follow-up Form.
Returned Inadmissible Contact 835 1 5/60 70
Passenger. information
collection for
public health
follow up.
Airline Representative........ Contact 835 1 10/60 139
information
collection for
public health
follow up.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 352,538,030
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-24994 Filed 11-15-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 16, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.